ARTICLE | Clinical News

DTC 101: Started Phase III trials in 120 patients whose tumors have spread to the membranes covering the spinal cord and brain; patients with three subtypes of

March 7, 1994 8:00 AM UTC

DepoTech Corp., La Jolla, Calif. Product: DTC 101, an injectable sustained-release form of cytarabine, encapsulated in DepoFoam lipid-based drug delivery system Indication: Neoplastic meningitis Stat...